Abstract The clinical outcomes associated with using commercial versus open ISDTs (initial specimen diverting techniques) remain unclear. This multicenter study showed that switching from the commercial to open ISDT did not change blood culture contamination rates, length of stay, or days of therapy with antibiotics, but did reduce laboratory-associated costs.
Yang et al. (Thu,) studied this question.